WITH ENDEXO ADVANCED TECHNOLOGY TECHNOLOGY DESIGNED TO IMPROVE ADVANCED TECHNOLOGY SOLUTIONS OUTCOMES* PATIENT OUTCOMES COST EFFECTIVE
|
|
- Bernard Lawrence
- 6 years ago
- Views:
Transcription
1 WITH ENDEXO TECHNOLOGY ADVANCED TECHNOLOGY ADVANCED TECHNOLOGY SOLUTIONS DESIGNED TO IMPROVE PATIENT OUTCOMES DESIGNED TO IMPROVE OUTCOMES* COST EFFECTIVE
2 ADVANCED TECHNOLOGY DESIGNED TO IMPROVE OUTCOMES* Reduces the risk of thrombus accumulation on implantable vascular devices from 83% to 96%. * Reinventing the standard of care by reducing the risk of thrombus accumulation. EVOLVE TO ADVANCED CATHETER TECHNOLOGY COST EFFECTIVE Reduction in thrombus accumulation results in a decrease in catheterrelated thrombus/ occlusions and the associated costs. Vascular access procedures are one of the most common procedures performed on patients in hospitals. AngioDynamics is committed to creating strategic partnerships with healthcare institutions to address today s changing healthcare environment by developing advanced technology that are safe, cost effective and designed to improve * The Endexo catheter is designed to reduce thrombus accumulation. The reduction of thrombus accumulation (based on platelet count) is supported by acute in-vitro testing. Pre-clinical in-vitro evaluations do not necessarily predict clinical performance with respect to thrombus formation. patient outcomes.
3 COMMON VASCULAR ACCESS DEVICE COMPLICATIONS THROMBOSIS OCCLUSION PICC-related upper extremity DVT occurs at an average rate of %1 with an average cost of $15,9732 per incidence. 25% average occlusion rate, most frequent complication of vascular access devices.3 Single dose of thrombolytic $ * CATHETER-RELATED INFECTIONS Estimated 250,000 blood stream infections occur annually in the United States, resulting in significantly higher mortality rates and costs in hospital inpatients.5 *Market price for single dose of CathFlo 1. Chopra V, Anand S, Krein SL, Chenoweth C, Saint S. Bloodstream infection, venous thrombosis, and peripherally inserted central catheters: reappraising the evidence. Am J Med Aug;125(8): doi: /j.amjmed Zochios V, Umar I, Simpson N, Jones N. Peripherally inserted central catheter (PICC)-related thrombosis in critically ill patients. J Vasc Access. 2014;15(5): Moll S, Kenyon P, Bertoli L, De Maio J, Homesley H, Deitcher SR. Phase II Trial of Alfimeprase, a Novel-Acting Fibrin Degradation Agent, for Occluded Central Venous Access Devices. J Clin Oncol Jul 1;24(19): Sapienza SP, Ciaschini DR. Intraluminal Volume Dose Alteplase for the Clearance of Occluded Peripherally Inserted Central Catheter Lines at a Long-Term Acute Care Hospital: Efficacy and Economic Impact. Hosp Pharm Mar;50(3): doi: /hpj Stevens V, Geiger K, Concannon C, Nelson RE, Brown JK, Dumyati G. Inpatient costs, mortality and 30-day re-admission in patients with central-line-associated bloodstream infections. Clin Microbiol and Infect (2014);20(5): doi: / Virchow s Triad Vessel Injury Hypercoagulability Venous Stasis Common Vascular Access Complications Catheter Occlusions CLABSI DVT VTE Chopra V, Flanders SA, Saint S, Woller SC, O Grady NP, Safdar N, Trerotola SO, Saran R, Moureau N, Wiseman S, Pittiruti M, Akl EA, Lee AY, Courey A, Swaminathan L, LeDonne J, Becker C, Krein SL, Bernstein SJ; Michigan Appropriateness Guide for Intravenous Catheters (MAGIC) Panel. The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): Results from a Multispecialty Panel Using the RAND/UCLA Appropriateness Method. Ann Intern Med Sep 15;163(6 Suppl):S1-40. doi: /M
4 MICHIGAN APPRORIATENESS GUIDE INTRAVENOUS CATHETERS Selecting a vascular device will always be a nuanced clinical decision. But a little bit of MAGIC almost certainly helps... Naomi O Grady, MD This work represents an important achievement the first time so many specialties were brought together to focus on vascular access... Lisa Gorski, RN Our research is focused on: (a) understanding drivers of PICC use and preventing inappropriate insertion; (b) developing statistical models that predict PICC complications; and (c) designing and implementing interventions to prevent adverse events such as occlusion, thromboembolism, and infection. We work closely with a number of key partners to achieve these goals. ADDRESSABLE COMPLICATIONS: PICC-RELATED We ve gravitated towards using this device [PICC] over central venous catheters for good reasons, and it may still be the best choice for some people. However, our findings suggest that patients and physicians should carefully review the risks and benefits when it comes to placing PICCs, especially with respect to blood clots. Our study shows that this risk may be higher than previously recognized and suggests that there is no one-size-fits-all approach when considering use of these devices. Vineet Chopra, MD For healthcare quality officers and payers, MAGIC is highly relevant because it will facilitate measuring practice and inform quality improvement efforts... Scott Woller, MD MAGIC is a set of recommendations that defines when a particular vascular access device is appropriate for use. Written by 14 of the world s foremost experts and a patient, MAGIC covers the most commonly used IV devices, indications, patient types, and settings for use. In the world of vascular access, there is nothing else like it. Chopra V, Flanders SA, Saint S, Woller SC, O Grady NP, Safdar N, Trerotola SO, Saran R, Moureau N, Wiseman S, Pittiruti M, Akl EA, Lee AY, Courey A, Swaminathan L, LeDonne J, Becker C, Krein SL, Bernstein SJ; Michigan Appropriateness Guide for Intravenouse Catheters (MAGIC) Panel. The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): Results from a Multispecialty Panel Using the RAND/UCLA Appropriateness Method. Ann Intern Med Sep 15;163(6 Suppl):S1-40. doi: /M Mostafavi, B. U-M Press Release. Commonly used catheters double risk of blood clots in ICU and cancer patients. May 19, Available at archive/201305/commonly-used-catheters-double-risk-blood-clots-icu-and. Chopra V, Flanders SA, Saint S, Woller SC, O Grady NP, Safdar N, Trerotola SO, Saran R, Moureau N, Wiseman S, Pittiruti M, Akl EA, Lee AY, Courey A, Swaminathan L, LeDonne J, Becker C, Krein SL, Bernstein SJ; Michigan Appropriateness Guide for Intravenous Catheters (MAGIC) Panel. The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): Results from a Multispecialty Panel Using the RAND/UCLA Appropriateness Method. Ann Intern Med Sep 15;163(6 Suppl):S1-40. doi: /M
5 HISTORY OF VASCULAR ACCESS MATERIALS EVOLVE TO ENDEXO TECHNOLOGY SILICONE POLYURETHANE COATED IMPREGNATED ENDEXO
6 COATED Catheter coatings are present on the catheter surface and known to elude off once they are placed inside the body and begin to lose their platelet adhesion resistance. IMPREGNATED Impregnated catheters claim to offer thrombusreducing properties in their pores, leaving the surface vulnerable to platelet adhesion. EVOLUTION TO ENDEXO ENDEXO Unlike other technologies that are superficial and/or transient, Endexo technology is present for the life of the catheter. EVOLUTION OF CATHETER TECHNOLOGY The Endexo polymer mixes with carbothane completely without altering the base properties. Due to the lower surface friction of the Endexomodified polymer, the material becomes essentially invisible to normal biological defense mechanisms. Thus platelet accretion, clot formation and histochemical reactivity is significantly reduced. 1 Endexo alters the surface chemistry of the device. 2 The surface reduces the rate of bioaccretion. 3 Endexo mixes into the parent polymer seamlessly. The non-stick characteristics of the Endexo material and resultant catheter construction reduce the adherence of blood components, such as platelets and thrombus. Not containing heparin, the Endexo technology may help to minimize complications associated with heparin. Additionally, the Endexo technology does not contain antibiotics or antimicrobial agents, aiding to reduce potential complications associated with bacterial resistance. The Endexo material is throughout the catheter (i.e., inside, outside and cut surfaces) and remains for the life of the device. In fact, the exposure of the BioFlo PICC to simulated implant flow conditions (i.e., temperature, flow, ph and time) demonstrated that the Endexo polymer concentration within the BioFlo PICC did not degrade or change over extended durations. Lareau R, Facchini F. A New Option for Short- or Long-Term Peripheral Access to the Central Venous System: A Product Technology Overview of the BioFlo PICC with Endexo Technology, with and without PASV Valve Technology AngioDynamics.
7 PERFORMANCE IN IN-VITRO EVALUATIONS BLOOD LOOP (IN VITRO): RESULTS High-magnification images of blood loop samples show that the BioFlo PICC has a marked reduction in thrombus when compared to control BioFlo PICC 5 F DL Catheter has no visible thrombus, fibrin sheath, or clot 5 F DL Competitive PICC Catheter with significant thrombus accumulation FACILITY NAME # OF PICCs PLACED DVT REDUCTION Academic Medical Center 1,251 85% Community Hospital % Community Hospital 1,212 36% Hospital Group % International Hospital 60 46% Health System 3,881 30% Academic Medical Center 52 55% 7,241 51% FACILITY NAME # OF PICCs PLACED tpa REDUCTION Children s Hospital % Community Hospital % Community Hospital 1,212 62% Hospital Group % 2,474 68% PERFORMANCE IN CLINICAL EVALUATIONS AVG REDUCTION WITH THIS DATA SET 51% DVTs 68% tpa Data on file. Data on file. Data was obtained during hospital product evaluations, several of these sites are working toward publications. Based on data collected at individual institutions, results may not be indicative of clinical experiences at other institutions. McLennan G, Kertesz M, Obuchowski N, Sands M. Flouroquinolone Based Surface Modifying Molecules Reduce Venous Thrombosis Rates Associated with PICC Lines. RSNA 2014 Scientific Assembly and Annual Meeting. Abstract. Sustar L, Kertesz M. Anti-Thrombogenic Non-Eluting Polyurethane PICC vs. Conventional Polyurethane PICC Upper Extremity DVT Rates AVA Annual Scientific Meeting. Poster Presentation. Rineair SA, Webb JL. Changing the Outcome for the Pediatric Peripherally Inserted Central Catheter Patient: Decreasing Occlusion Complications with the Implementation of an Alternative Peripherally Inserted Central Catheter AVA Annual Scientific Meeting. Poster Presentation. Corbin D, Crites L. Reducing Catheter-Related Complications with New Anti-Thrombogenic PICC AVA Annual Scientific Meeting. Poster Presentation. Simcock L, Salvador J, McInerney K, Bhavika P. A Retrospective Comparative Audit of Whether BioFlo PICCS Can Reduce the Incidence of Upper Extremity-Deep Vein Thrombosis in Patients with Sarcoma AVA Annual Scientific Meeting. Poster Presentation. Cox S, Wheeler K. Venous Thromboembolism Prevention: An Innovative Approach to Improving Quality and Safety in a Neuro ICU. Poster Presentation.
8 RISK REDUCTION: SINGLE CENTER PROSPECTIVE HOSPITAL STUDY 12.00% 10.00% 8.00% 6.00% 4.00% 2.00% 0.00% OCCLUSIONS Standard Polyurethane Anti-Thrombogenic Endexo BioFlo PASV PICC UEDVTs RISK REDUCTION: SINGLE-CENTER RETROSPECTIVE STUDY (24 Months) 30% Reduction in UEDVTs as Compared to Standard Polyurethane 3,891 Patients Endexo 8,323 Total Patients Polyurethane 4,432 Patients The complication rates were tracked and calculated for the following metrics: Occlusions: Standard polyurethane PICC 10.2%, anti-thrombogenic PICC 2.8% (73% reduction). UEDVTs: Standard polyurethane PICC 1.4%, anti-thrombogenic PICC 0.3% (80% reduction). Average Monthly Cathflo Expense: Standard polyurethane PICC $1,638.89, anti-thrombogenic PICC $ (64% reduction). 2.1% UEDVT Rate 30% Reduction in UEDVTs 3.1% UEDVT Rate These results are based on individual site experiences and may not be indicative of clinical evidence at other institutes. Crites L. Reducing Catheter-Related Complications With New Anti-Thrombogenic PICC (Abstract). Journal of the Association for Vascular Access. 2015;20(4):256. ANGM 145 US. Mostafavi, B. U-M Press Release. Commonly used catheters double risk of blood clots in ICU and cancer patients. May 19, Available at archive/201305/commonly-used-catheters-double-risk-blood-clots-icu-and. UEDVT= Upper Extremity Deep Vein Thrombosis Polenakovik H, Patton A, Jenkins J. Reducing Upper Extremity Deep Vein Thrombosis in the Peripherally Inserted Central Catheter Patient Association for Vascular Access Annual Scientific Meeting - National Harbor, MD. Poster Presentation (C-13). ANGM 148 US.
9 TRENDS IN HEALTH CARE ECONOMICS REGULATORY PAYORS HOSPITALS PHYSICIANS PATIENTS PICC PORT ANGIODYNAMICS IS THE ONLY PROVIDER OF ENDEXO TECHNOLOGY FOR VASCULAR ACCESS DEVICES. Changes in Reimbursement Bundled Payment Models Quality Measures More Transparency INCREASING NEED FOR CLINICAL AND HEALTHCARE QUALITY DATA DIALYSIS CATHETER MIDLINE ENDEXO PROVIDES A SAFE, COST- EFFECTIVE, ADVANCED TECHNOLOGY DESIGNED TO IMPROVE PATIENT OUTCOMES.
10 IMPORTANT RISK INFORMATION BIOFLO PICC WITH ENDEXO AND PASV VALVE TECHNOLOGY INTENDED USE/INDICATIONS FOR USE: The BioFlo PICC with Endexo and PASV Valve Technology is indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications and nutrients; the sampling of blood; and for power injection of contrast media. CONTRAINDICATIONS: Venous thrombosis in any portion of the vein to be catheterized. Conditions that impede venous return from the extremity such as paralysis or lymphedema after mastectomy. Orthopedic or neurological conditions affecting the extremity. Anticipation or presence of dialysis grafts or other intraluminal devices. Hypercoagulopathy unless considerations are made to place the patient on anticoagulation therapy. Pre-existing skin surface or subsurface infection at or near the proposed catheter insertion site. Anatomical distortion of the veins from surgery, injury or trauma. Inadequate antecubital veins. Anatomical irregularities (structural or vascular) which may compromise catheter insertion or catheter care procedures. Refer to Directions for Use provided with the product for complete instructions, warnings and precautions. CAUTION: Federal Law (USA) restricts this device to sale by or on the order of a physician. BIOFLO PORTS WITH ENDEXO TECHNOLOGY INTENDED USE/INDICATIONS FOR USE: The BioFlo Port is indicated for patient therapies requiring repeated access to the vascular system. The port system can be used for infusion of medications, IV fluids, parenteral nutrition solutions, blood products and for the withdrawal of blood samples. When used with a power injectable needle, the BioFlo Port is indicated for power injection of contrast media. For power injection of contrast media, the maximum recommended infusion rate is 5 ml/sec with a 19 G or 20 G non-coring power injectable needle or 2 ml/sec with a 22 G noncoring power injectable needle. CONTRAINDICATIONS: Inadequate body size to support device, bacteraemia, sepsis, known or suspected allergic response to materials, infection, peritonitis, past irradiation of prospective insertion site, previous episodes of venous thrombosis or vascular surgical procedures at the postoperative placement site, local tissue factors will prevent proper device stabilization and/or access. Refer to package insert provided with the product for complete Instructions for Use, Contraindications, Possible Complications, Warnings and Precautions prior to using this product. CAUTION: Federal Law (USA) restricts this device for sale by or on the order of a physician. BIOFLO DURAMAX DIALYSIS CATHETER WITH ENDEXO TECHNOLOGY INDICATIONS FOR USE: The BioFlo DuraMax Dialysis Catheter with Endexo Technology is indicated for use in attaining long-term vascular access for hemodialysis and apheresis in adults. Catheters greater than 40 cm are intended for femoral vein insertion. CONTRAINDICATIONS: The catheter is intended for long-term vascular access only and should not be used for any purpose other than indicated in the instructions for use. WARNINGS AND PRECAUTIONS: Please see package insert for complete list of warnings and precautions. POTENTIAL COMPLICATIONS: Consult package insert for a complete list of potential complications. Indications, contraindications, warnings and instructions for use can be found in the instructions for use supplied with each device. Observe all instructions prior to use. Failure to do so may result in patient complications. CAUTION: Federal Law (USA) restricts this device to sale by or on the order of a physician. BIOFLO MIDLINE CATHETER WITH ENDEXO TECHNOLOGY INTENDED USE/INDICATIONS FOR USE: The BioFlo Midline catheter with ENDEXO technology is indicated for short-term access (< 30 days) to the peripheral venous system for intravenous therapy, including but not limited to, the administration of fluids, medications, and the sampling of blood and blood products. CONTRAINDICATIONS: Venous thrombosis in any portion of the vein to be catheterized. Conditions that impede venous return from the extremity such as paralysis or lymphedema after mastectomy. Orthopedic or neurological conditions affecting the extremity. Anticipation or presence of dialysis grafts or other intraluminal devices, including pacemakers. Hypercoagulopathy unless considerations are made to place the patient on anticoagulation therapy. Pre-existing skin surface or subsurface infection at or near the proposed catheter insertion site. Anatomical distortion of the veins from surgery, injury or trauma. Inadequate antecubital veins. Anatomical irregularities (structural or vascular) which may compromise catheter insertion or catheter care procedures. Refer to Directions for Use provided with the product for complete instructions, warnings, precautions and potential complications. CAUTION: Federal Law (USA) restricts this device to sale by or on the order of a physician. AngioDynamics, the AngioDynamics logo, Navilyst Medical, PASV, BioFlo and the BioFlo logo are trademarks and/or registered trademarks of AngioDynamics, Inc., an affiliate or a subsidiary. Endexo is a trademark and/or registered trademark of Interface Biologics, Inc.AngioDynamics, the AngioDynamics logo, Navilyst Medical, PASV, BioFlo and the BioFlo logo are trademarks and/or registered trademarks of AngioDynamics, Inc., an affiliate or a subsidiary. Endexo is a trademark and/or registered trademark of Interface Biologics, Inc.
11 ANGB 218 GL Rev 06
BioFlo PICC. with Endexo and PASV Valve Technology. Clinician Reference Tool
BioFlo PICC with Endexo and PASV Valve Technology Clinician Reference Tool BioFlo * PICC with Endexo * and PASV * Valve Technology The FIRST and only power injectable PICC that integrates Endexo Technology
More informationNuovi materiali per la prevenzione di infezione e trombosi: quali evidenze?!
Nuovi materiali per la prevenzione di infezione e trombosi: quali evidenze?! Massimo Lamperti MD, MBA! Clinical Professor of Anesthesiology! Cleveland Clinic Lerner College of Medicine! Chief of General
More informationVaxcel Implantable Ports Valved and Non-Valved. A Patient s Guide
Vaxcel Implantable Ports Valved and Non-Valved A Patient s Guide Vaxcel Implantable Port This pamphlet provides some answers to questions you may have about your implantable port and how to care for it
More informationAdvancing Lives and the Delivery of Health Care. The High-Flow Port Designed for Apheresis
Advancing Lives and the Delivery of Health Care The High-Flow Port Designed for Apheresis Optimized for Long Device Life Bench Tested up to 1,000 Accesses 1 Bard is proud to introduce the first and only
More informationCatheter-Related Thrombosis A Catalyst of Complications
Catheter-Related Thrombosis A Catalyst of Complications Catheter-Related Occlusions 1,2 Most common non-infectious complication in the long-term use of CVCs, and in particular PICCs Approximately 1 in
More informationThe High-Flow Port Designed & Indicated for Apheresis
The High-Flow Port Designed & Indicated for Apheresis Advancing Lives and the Delivery of Health Care Bard is proud to introduce the first and only high-flow, power-injectable port designed and indicated
More informationDon't place, or leave in place, peripherally inserted central catheters for patient or provider convenience.
Society of General Internal Medicine Choosing Wisely 5 Things Physicians & Patients Should Question April, 2016 Original authors (2013): Vineet Chopra, Laurence McMahon, Jr. Updated by Robert Fogerty,
More information2018 HEMODIALYSIS CATHETERS CODING AND REIMBURSEMENT GUIDE
2018 HEMODIALYSIS CATHETERS CODING AND REIMBURSEMENT GUIDE Contents Overview of Central Venous Access s for Hemodialysis 2 Procedures Using Hemodialysis s 2 Physician Reimbursement for Hemodialysis s 3
More informationPer-Q-Cath* PICC Catheters with Excalibur Introducer* System
Bard Access Systems Per-Q-Cath* PICC and Catheters with Excalibur Introducer* System Instructions For Use Table of Contents Table of Contents Page Contents 1 Product Description, Indications & Contraindications
More informationDesigned to Reduce the Risk of Occlusion (1)
Designed to Reduce the Risk of Occlusion (1) more efficient flushing better outcomes The Vortex* ports feature the Vortex Technology for a more efficient flushing. The Vortex Technology sets up efficient
More informationThe Use of PICCs Within Critical Care. Lynn Hadaway, M.Ed., RN-BC, CRNI
The Use of PICCs Within Critical Care Lynn Hadaway, M.Ed., RN-BC, CRNI Disclosure Lynn Hadaway is a paid consultant for B Braun of Canada, Ltd Development and delivery of this presentation was commissioned
More informationRESTORING PATENCY TO CENTRAL VENOUS ACCESS DEVICES
RESTORING PATENCY TO CENTRAL VENOUS ACCESS DEVICES Indications Venous access is poor Intravenous therapy involves venous sclerosants Ambulatory chemotherapy given as an outpatient Repeated sampling, or
More informationThe Impact of Catheter Occlusion in Central Line Associated Bloodstream Infections M A R C H 15, 2017
The Impact of Catheter Occlusion in Central Line Associated Bloodstream Infections D A R C Y DOELLMAN M S N, RN, CRNI, VA - BC M A R C H 15, 2017 LOUISVILLE, KENTUCKY Cincinnati Children s Hospital 642
More informationDVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center
DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients David Liff MD Oklahoma Heart Institute Vascular Center Overview Pathophysiology of DVT Epidemiology and risk factors for DVT in the
More informationInhixa (Enoxaparin Sodium)
Inhixa (Enoxaparin Sodium) P R E V ENTIS SAFETY D E V I C E P R E V E N T I S I S A N AU TO M AT I C N E E D L E S H I E L D I N G S Y S T E M, W H I C H H A S A C O V E R T H AT E X T E N D S O V E R
More informationProven Performance Through Innovative Design *
Proven Performance Through Innovative Design * Deliver Our Next Generation AV Covered Stent Results The COVERA Vascular Covered Stent builds upon proven technologies from the category leader in AV Access.
More informationUltrasound for Vascular Access
Ultrasound for Vascular Access Now pocket-sized, cordless, portable, and affordable. Introduction An estimated 300 million vascular catheters are placed every year in the United States making vascular
More informationIV therapy. By: Susan Mberenga, RN, MSN. Copyright 2016, 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc.
IV therapy By: Susan Mberenga, RN, MSN 1 IV Therapy Types of solutions Isotonic Hypotonic Hypertonic Caution: Too rapid or excessive infusion of any IV fluid has the potential to cause serious problems
More informationEKOS. Interventional Vascular 3 February, Imagine where we can go.
EKOS Interventional Vascular 3 February, 2015 Imagine where we can go. Forward-looking statement This presentation and information communicated verbally to you may contain certain projections and other
More informationThe C.L.O.T. Tool for Identifying Strategies to Prevent PICC Catheter Occlusions
The C.L.O.T. Tool for Identifying Strategies to Prevent PICC Catheter Occlusions page 2 TABLE OF CONTENTS Part 1: Definition and Scope of Catheter Occlusion Part 2: Predictors of Catheter Occlusion Part
More informationCatheter Vessel Ratio : Now What?
Catheter Vessel Ratio : Now What? Timothy R Spencer, DipAppSc, BHealth, IC Cert, RN, APN, VA-BCTM Keegan J Mahoney, BS, RRT, VA-BCTM Vascular Access Specialist, Global Vascular Access, Scottsdale AZ Vascular
More informationReaching New Heights in Understanding Central Venous Catheter Thrombosis
Reaching New Heights in Understanding Central Venous Catheter Thrombosis Lynn Manly, RN, CRNI, VA BC, Clinical Director, Navilyst Medical, Tarpon Springs, FL Top 4 Things to Know for CE 1. Make sure your
More informationReaching New Heights in Understanding Central Venous Catheter Thrombosis
Reaching New Heights in Understanding Central Venous Catheter Thrombosis Lynn Manly, RN, CRNI, VA BC, Clinical Director, Navilyst Medical, Tarpon Springs, FL Top 4 Things to Know for CE 1. Make sure your
More informationPARENTERAL NUTRITION: VASCUAR ACCESS DEVICE SELECTION
PARENTERAL NUTRITION: VASCUAR ACCESS DEVICE SELECTION Winifred Magambo-Gasana Vascular Access Nurse Practitioner Oxford University Hospitals NHS Foundation Trust Aim An overview of the range of Vascular
More informationAXS Catalyst Distal Access Catheter
AXS Catalyst Distal Access Catheter Directions for Use 2 AXS Catalyst Distal Access Catheter ONLY Caution: Federal Law (USA) restricts this device to sale by or on the order of a physician. warning Contents
More informationPrevent Bloodstream Infections by Using Appropriate Devices
37 Prevent Bloodstream Infections by Using Appropriate Devices Situation Catheter-associated infections include exit, tunnel, pocket and bloodstream infections. In the United States, when these types of
More informationReliable venous access is a cornerstone of safe and
Annals of Internal Medicine SUPPLEMENT The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): Results From a Multispecialty Panel Using the RAND/UCLA Appropriateness Method Vineet Chopra,
More informationFLEXIC ATH LTD. Peripherally Inserted. Instructions n For Use.
FLEXIC ATH LTD * M/29M Peripherally Inserted Catheter Instructions n For Use This leaflet contains instructions for both stan- dard needle-introducer er and protection con- tained M/29 models, i.e., with
More informationVascular access in practice: best practice update
Vascular access in practice: best practice update Nicola York Clinical Nurse Manager Vascular Access Oxford University Hospitals NHS Foundation Trust June 2016 Objectives Patient assessment Best practice
More informationDirections For Use. All directions should be read before use
Directions For Use All directions should be read before use DEVICE DESCRIPTION: The CLEANER.XT Rotational Thrombectomy System is a percutaneous, 6Fr catheter based system (single piece construction) that
More informationTYPES AND USES OF VENOUS ACCESS DEVICES
FOR HEALTHCARE PROVIDER USE ONLY. THIS INFORMATION IS FOR REFERENCE PURPOSES ONLY AND DOES NOT TYPES AND USES OF VENOUS ACCESS DEVICES PERIPHERAL DEVICES 1 Typically inserted in the hand, arm, or foot
More informationPeel-Apart Percutaneous Introducer Kits for
Bard Access Systems Peel-Apart Percutaneous Introducer Kits for Table of Contents Contents Page Bard Implanted Ports Hickman*, Leonard*, Broviac*, Tenckhoff*, and Groshong* Catheters Introduction....................................
More informationAn Economic Analysis of Midline Venous Catheters to Reduce IV Contrast Extravasation
An Economic Analysis of Midline Venous Catheters to Reduce IV Contrast Extravasation Antony Hayes, MD 1 D. Lee Bennett, MD, MBA 1,2 1 University of Iowa Hospitals and Clinics, Iowa City, IA 2 University
More informationCADTH RAPID RESPONSE REPORT: SUMMARY WITH CRITICAL APPRAISAL
CADTH RAPID RESPONSE REPORT: SUMMARY WITH CRITICAL APPRAISAL Central Venous Access Devices (CVADs) and Peripherally Inserted Central Catheters (PICCs) for Adult and Pediatric : A Review of Clinical Effectiveness
More informationESPEN Congress Florence 2008
ESPEN Congress Florence 2008 Complications of Central Venous Catheters EPIDEMIOLOGY & DIAGNOSIS & PREVENTION Federico Bozzetti (Italy) CVC COMPLICATIONS EPIDEMIOLOGY & DIAGNOSIS & PREVENTION Federico Bozzetti
More informationMary Lou Garey MSN EMT-P MedFlight of Ohio
Mary Lou Garey MSN EMT-P MedFlight of Ohio Function Prolonged and frequent access to venous circulation Allows for patient to carry on normal life; decrease number of needle sticks Medications, parenteral
More informationCLOSES WITH SECURITY. LEAVES WITHOUT A TRACE.
CLOSES WITH SECURITY. LEAVES WITHOUT A TRACE. Close with Confidence. Leave Nothing Behind. The innovative design and predictable deployment of MYNX CONTROL Vascular Closure Device (VCD) delivers outstanding
More informationRuby Coil. Large Volume Detachable Coils
Ruby Coil Ruby Case Examples 38 mm Hepatic Artery Aneurysm Pulmonary AVM 2 Coils Dr. James Benenati Miami Cardiac and Vascular Institute, FL Y90 Embolization Type 2 Endoleak Dr. J Moskovitz Florida Hospital,
More informationBTK Case Studies Joseph Cardenas, MD AZ Heart & Vascular, Yuma, AZ
BTK Case Studies Joseph Cardenas, MD AZ Heart & Vascular, Yuma, AZ 1 Case 1 78 yr. old female Rutherford Class II/III lesion 1 block claudicant 2 Pre Treatment Post Treatment Anterior Tibial Artery Occlusion
More informationSlide 1. Slide 2 Disclosures. Slide 3 Learning Objectives. Catheter-Related Thrombosis and Infection: Reducing Controllable Risk Factors
Slide 1 Catheter-Related Thrombosis and Infection: Reducing Controllable Risk Factors Thomas P. Nifong, MD Vice President, Clinical Operations Metamark Genetics, Inc Cambridge, Massachusetts USA Slide
More informationThe SplitWire Percutaneous Transluminal Angioplasty Scoring Device. Instructions for Use
The SplitWire Percutaneous Transluminal Angioplasty Scoring Device Instructions for Use Contents Contains one (1) SplitWire device. Sterile. Sterilized with ethylene oxide gas. Radiopaque. For single use
More informationClinical Policy: Dalteparin (Fragmin) Reference Number: ERX.SPA.207 Effective Date:
Clinical Policy: (Fragmin) Reference Number: ERX.SPA.207 Effective Date: 01.11.17 Last Review Date: 02.18 Revision Log See Important Reminder at the end of this policy for important regulatory and legal
More informationNavigating Vascular Access Issues
Navigating Vascular Access Issues The Oley Foundation 27 th Annual Consumer/Clinician Conference Redondo Beach, CA June, 27 2012 Anita Piano, BS, RN, VA-BC Administrative Nurse, PICC Service UCLA Health
More information2015 Facility and Physician Billing Guide Heart Valve Technologies
2015 Facility and Physician Billing Guide Heart Valve Technologies PHYSICIAN BILLING CODES Clinicians use Current Procedural Terminology (CPT 1 ) codes to bill for procedures and services. Each CPT code
More informationIR Central Venous Access [ ] Pre Procedure
IR Central Venous Access [1050200001] Pre Procedure Case Request/Scheduling Procedure Enter IR Case Request if not already completed (All hospitals except Grant Medical Center) [ ] Case Request IR Lab
More informationA CATHETER FAMILY FOR ALL YOUR PATIENT NEEDS
A CATHETER FAMILY FOR ALL YOUR PATIENT NEEDS MAHURKAR * Elite acute dialysis catheter family EFFICIENCY OF DIALYSIS IN REVERSE FLOW Less than one percent recirculation Symmetrical tip design minimizes
More informationTITLE: Peripherally Inserted Central Catheters (PICCs) for Adult and Pediatric Patients: A Review of Clinical Evidence
TITLE: Peripherally Inserted Central Catheters (PICCs) for Adult and Pediatric Patients: A Review of Clinical Evidence DATE: 5 April 2013 CONTEXT AND POLICY ISSUES Peripherally inserted central catheters
More informationAcoustic Pulse Thrombolysis Treatment
Acoustic Pulse Thrombolysis Treatment BTGVascular.com SETTING THE STANDARD FOR VASCULAR THERAPIES Quickly & safely dissolve thrombus with the EKOS System. The Acoustic Pulse Difference Acoustic Pulse Thrombolysis
More informationBioFlo PICC. with ENDEXO Technology. Directions For Use A
BioFlo PICC with ENDEXO Technology Directions For Use... 3 Navilyst Medical, Master DFU Template 8in x 8in Global, 146T0808 Rev/Ver. A, DFU, BioFlo PICCwith ENDEXO Technology, 14600123-01A 14600123-01
More informationSystem.
System www.penumbrainc.com POD System Case Examples 45 cm of POD Packing Coil in 1.5 to 3 mm diameter dilating vessel Bronchial Artery Embolization Dr. Amit Kakkar and Dr. Aksim Rivera, Bronx, NY Inflow:
More informationCOVERA Vascular Covered Stents in the Management of Dysfunctional AV Access
COVERA Vascular Covered Stents in the Management of Dysfunctional AV Access Bart L. Dolmatch, M.D., FSIR Palo Alto Medical Foundation Mountain View, CA USA This presentation is being made on behalf of
More informationXcela Hybrid PICC with PASV Valve Technology
Xcela Hybrid PICC with PASV Valve Technology Directions For Use...3 Navilyst Medical, Master DFU Template 8in x 8in Global, 146T0808 Rev/Ver. A, DFU, XCELA HYBRID PICC w/ PASV VALVE TECHNOLOGY, 14600125-01A
More informationIdentification and Management of Central Vascular Access Device Complications
Identification and Management of Central Vascular Access Device Complications David Hahn, MD Interventional Radiology NorthShore University HealthSystem Evanston, Illinois Disclosures Consultant, AngioDynamics,
More informationVascular Access Options for Apheresis Medicine
Vascular Access Options for Apheresis Medicine Josh King, MD Divisions of Nephrology and Medical Toxicology University of Virginia September 21, 2018 Disclosure I have no personal or professional financial
More informationA Primer on Central Venous Access: Peripherally-Inserted Central Catheters, Tunneled Catheters, and Subcutaneous Ports
Disclosures A Primer on Central Venous Access: Peripherally-Inserted Central Catheters, Tunneled Catheters, and Subcutaneous Ports No conflicts of interest relevant to this presentation Jason W. Pinchot,
More informationPreventing Central Venous Catheter Complications- An evidence based approach
Preventing Central Venous Catheter Complications- An evidence based approach Srinivas Bapoje MD, MPH Director, Hospital Medicine Procedure Service Denver Health Medical Center Learning Objectives Discuss
More informationSupplementary Material* Supplement. Appropriateness Criteria for Vascular Access in Hospitalized Patients
Supplementary Material* Chopra V, Flanders SA, Saint S, Woller SC, O'Grady NP, Safdar N, et al. The Michigan Guide for Intravenous Catheters (MAGIC): Results From a Multispecialty Panel Using the RAND/UCLA
More informationInstructions for Use Reprocessed LASSO Circular Mapping Diagnostic Electrophysiology (EP) Catheter
Instructions for Use Reprocessed LASSO Circular Mapping Diagnostic Electrophysiology (EP) Catheter Caution: Federal (USA) law restricts this device to sale by or on the order of a physician. DEVICE DESCRIPTION
More informationThe New Medtech Economic Reality MassMEDIC Annual Meeting
The New Medtech Economic Reality MassMEDIC Annual Meeting Susan Posner Vice President sposner@healthadvances.com May 1, 2012 The New Medtech Reality The economic downturn coupled with the focus on health
More informationPrevention of thrombosis
Prevention of thrombosis Massimo Lamperti MD, MBA Chief of General Anaesthesia Department Anaesthesiology Institute Cleveland Clinic Abu Dhabi Clinical Professor of Anaesthesiology Cleveland Clinic Lerner
More informationWhat is TAVR? Transcatheter Aortic Valve Replacement
What is TAVR? Transcatheter Aortic Valve Replacement What Are Your Options for Treating Severe Aortic Stenosis? Treatment for aortic stenosis depends on how far your disease has progressed. If your stenosis
More informationClinical Practice Guideline on Central Venous Catheter Care for the Patient with Cancer
Clinical Practice Guideline on Central Venous Catheter Care for the Patient with Cancer COG Supportive Care Endorsed Guidelines Click here to see all the COG Supportive Care Endorsed Guidelines. DISCLAIMER
More informationDEEP VEIN THROMBOSIS (DVT): TREATMENT
DEEP VEIN THROMBOSIS (DVT): TREATMENT OBJECTIVE: To provide an evidence-based approach to treatment of patients presenting with deep vein thrombosis (DVT). BACKGROUND: An estimated 45,000 patients in Canada
More informationDocument No. BMB/IFU/40 Rev No. & Date 00 & 15/11/2017 Issue No & Date 01 & 15/11/2017
Central Venous Catheter Device Description Multi-lumen catheters incorporate separate, non-communicating vascular access lumens within a single catheter body. Minipunctur Access Sets And Trays: Used for
More informationSuccessful IV Starts Revised February 2014
Successful IV Starts Revised February 2014 Why Intravenous Therapy? Used for access to the body s circulation Indications: Administer fluids, blood, medications, and nutrition Obtain laboratory specimens
More informationPERFORMANCE YOU CAN TRUST. EverFlex Self-expanding Peripheral Stent with Entrust Delivery System
PERFORMANCE YOU CAN TRUST EverFlex Self-expanding Peripheral Stent with Entrust Delivery System The Entrust Delivery System is designed to provide improved patient outcomes and procedural efficiency. The
More informationIf viewing a printed copy of this policy, please note it could be expired. Got to to view current policies.
If viewing a printed copy of this policy, please note it could be expired. Got to www.fairview.org/fhipolicies to view current policies. Department Policy Code: D: PC-5555 Entity: Fairview Pharmacy Services
More informationCentral Line-Associated Infections (CLABSI) Settings Toolkit
Central Line-Associated Infections (CLABSI) in Non-Intensive Care Unit (non-icu) Settings Toolkit Activity C: ELC Prevention Collaboratives Alex Kallen, MD, MPH and Priti Patel, MD, MPH Division of Healthcare
More informationGroshong* PICC and Catheters
Bard Access Systems Groshong* PICC and Catheters Instructions For Use Table of Contents Table of Contents Page Contents 1 Product Description 2 Product Description, Indications & Contraindications 3 Contraindications,
More informationReducing catheter-related thrombosis using a risk reduction tool centered on catheter to vessel ratio
Reducing catheter-related thrombosis using a risk reduction tool centered on catheter to vessel ratio Timothy R. Spencer, DipAppSc, BHSc, ICCert, RN, APRN, VA-BC Disclosures Director, Global Vascular Access,
More informationUsing Big Data to Prevent Infections
Using Big Data to Prevent Infections A thought paper by Scalable Health Big Data Analytics Reduces Infections in Hospitals Healthcare Associated Infections (HAIs) are developed while patients are receiving
More informationDevice Preparation (all steps to be performed per standard interventional technique)
sertera Biopsy Device Instructions for Use Please read all information carefully. Failure to properly follow the instructions may lead to unintended consequences. Important: This package insert is designed
More informationUnderstanding Your Fluid Status During Dialysis and the Crit-Line. IV Monitor
Understanding Your Fluid Status During Dialysis and the Crit-Line IV Monitor IV 1 Understanding Your Fluid Status During Hemodialysis Welcome to understanding your fluid status during hemodialysis. This
More informationIs it Necessary to Verify Blood Return in Monthly Port Flushes?
Is it Necessary to Verify Blood Return in Monthly Port Flushes? Gloria B. Ascoli, RN, CRNI, Amy C. Brown, BSN, RN, Jessica L. Cooper, BSN, RN, Allison N. Crawford, BSN, RN, CRNI Background Research Aims
More informationVaricose Veins are a Symptom of Vein Disease. Now you can treat the source of your varicose veins with non-surgical endovenous laser treatment.
Varicose Veins are a Symptom of Vein Disease. Now you can treat the source of your varicose veins with non-surgical endovenous laser treatment. Approximately 1 in 5 adult Americans suffer from superficial
More informationVictoria Chapman BS, RN, HP (ASCP)
Victoria Chapman BS, RN, HP (ASCP) Considerations: Age Sex Body Composition Hydration Status Chemotherapy Use Access History Considerations: Immunosuppression Use Chemotherapy Frequency of plasma exchanges
More informationDialysis Event Protocol
Dialysis Event Protocol Introduction In 2009, more than 370,000 patients were treated with maintenance hemodialysis in the United States. 1 Hemodialysis patients require a vascular access, which can be
More informationProtecting Patients. Preserving Access.
MAHURKAR * Family of Acute Care Catheters Protecting Patients. Preserving Access. A full spectrum of acute care catheters for use in hemodialysis, apheresis, infusion and renal replacement therapy The
More informationC-THRU Anterior Spinal System
C-THRU Anterior Spinal System Surgical Technique Manufactured From Contents Introduction... Page 1 Design Features... Page 2 Instruments... Page 3 Surgical Technique... Page 4 Product Information... Page
More informationDirections For Use. All directions should be read before use. Page 1 of 8
Directions For Use All directions should be read before use Page 1 of 8 WARNING: For single use only. Do not reuse, reprocess or re-sterilize. Reuse, reprocessing or re-sterilization may compromise the
More informationROTABLATORTM. Peripheral. Rotational Atherectomy System. Quick Reference Cards
Peripheral ROTABLATORTM Rotational Atherectomy System Quick Reference Cards Technical Assistance: 1.800.949.6708 Customer Service: 1.888.272.1001 Complaints: 1.800.811.3211 Setup Video: www.bostonscientific.com/rotablatorsetup
More informationClinical Policy: Dalteparin (Fragmin) Reference Number: ERX.SPA.207 Effective Date:
Clinical Policy: (Fragmin) Reference Number: ERX.SPA.207 Effective Date: 01.11.17 Last Review Date: 11.17 Revision Log See Important Reminder at the end of this policy for important regulatory and legal
More informationJo Kuehn, RN, MSN, CPHQ Jenell Westhoven, RN, BSN
Jo Kuehn, RN, MSN, CPHQ Jenell Westhoven, RN, BSN Disclosure Information Intravenous Therapy and Parenteral Nutrition Administration: Nursing In- Focus Jo Kuehn, RN, MSN, CPHQ and Jenell Westhoven, RN,
More informationIndications. The AngioVac cannula is intended for use as a venous drainage cannula and for the removal of fresh, soft thrombi or emboli
Indications Straight Cannula or Cannula with 20 O Angle 17F Working Channel The AngioVac cannula is intended for use as a venous drainage cannula and for the removal of fresh, soft thrombi or emboli Radiopaque
More informationBloodstream Infections
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER NUMBER 30: Bloodstream Infections Authors Larry Lutwick MD Gonzalo Bearman MD, MPH Chapter Editor Ziad A. Memish, MD, FRCPC, FACP Topic Outline Definition
More informationCATHETER ACCESS KIT. For use with Prometra Programmable Infusion Systems
CATHETER ACCESS KIT Caution: Federal (USA) Law restricts this device to sale by or on the order of a physician. Table of Contents Contents... 3 Description... 3 Indications... 3 Contraindications... 3
More informationUse of EKOS Catheter in the management of Venous Mr. Manoj Niverthi, Mr. Sarang Pujari, and Ms. Nupur Dandavate, The GTF Group
Use of EKOS Catheter in the management of Venous Thromboembolism @ Mr. Manoj Niverthi, Mr. Sarang Pujari, and Ms. Nupur Dandavate, The GTF Group Introduction Georgia Thrombosis Forum (GTF, www.gtfonline.net)
More informationExceptional Performance and Ease of Placement
Exceptional Performance and Ease of Placement S IMU LATED FLO W PERFO RMANC E Higher Flow Rates Higher is Better GLIDEPATH catheters demonstrated on average in forward Precision catheters Lower Pressures
More informationIschemic Stroke Therapies: Resource Guide
Ischemic Stroke Therapies: Resource Guide Ischemic Stroke Therapies Table of Contents Introduction...1 Stroke Protocol Roadmap...2 Public Awareness...3-4 Emergency Medical Services... 5-6 Emergency Department
More informationArrow-Clark VectorFlow Hemodialysis Catheter Because in Chronic Hemodialysis Catheters, the Tip Matters
Arrow-Clark VectorFlow Hemodialysis Catheter Because in Chronic Hemodialysis Catheters, the Tip Matters Because in chronic hemodialysis catheters, the tip matters Designed for Performance Tip design optimizes
More informationSafe-T-Centesis catheter drainage system. Innovations in patient safety, clinician safety and procedural efficacy.
Safe-T-Centesis catheter drainage system Innovations in patient safety, clinician safety and procedural efficacy. Safe-T-Centesis catheter drainage system This innovative drainage system is designed to
More informationProtecting Patients. Preserving Access.
MAHURKAR * Family of Acute Care Catheters Protecting Patients. Preserving Access. The Gold Standard Mahurkar * Acute Care Catheter Family Ease of insertion. Optimal flow rates. Patient comfort. A variety
More informationIt s the solution that counts. 3M skin antiseptic products
It s the solution that counts 3M skin antiseptic products SoluPrepTM Brand The impact of surgical site infections Surgical site infections (SSIs) are a major burden on healthcare systems, providers and
More informationTransjugular liver access and biopsy
Transjugular liver access and biopsy An illustrated guide Illustrations by Lisa Clark LABS LIVER ACCESS AND BIOPSY SET MEDICAL Support your procedures by using products that are specifically designed for
More informationPositioning System. Laparoscopic ventral hernia repair KEY BENEFITS SOFT TISSUE REPAIR
Echo PS Positioning System with Ventralight ST Mesh or Composix L/P Mesh Laparoscopic ventral hernia repair Echo PS Positioning System with Ventralight ST Mesh Echo PS Positioning System with Composix
More informationUnit 11. Objectives. Indications for IV Therapy. Intravenous Access Devices & Common IV Fluids. 3 categories. Maintenance Replacement Restoration
Unit 11 Fluids, Electrolytes and Acid Base Imbalances Intravenous Access Devices & Common IV Fluids Objectives Review the purpose and types of intravenous (IV) therapy. Recall the nursing care related
More informationAppendix E: Overview of Vascular
Appendix E: Overview of Vascular 56 Peripheral Short Catheter, less than 3 inches (7.5 cm) in length; over-the-needle catheter is most common. Inserted by percutaneous venipuncture, generally into a hand
More informationOptiFix Absorbable Fixation System
OptiFix Absorbable Fixation System Absorbable Fixation Redefined Advancing the Fixation Experience. SOFT TISSUE REPAIR Right Procedure. Right Product. Right Outcome. Hernia Repair Fixation Challenges and
More informationScope/Patient Population: This guideline applies to adult patients in the MultiCare Health System (MHS) critical care units.
DRAFT for review cycle 8/21/17 BEST PRACTICE GUIDELINE FOR THE INSERTION AND CARE OF CENTRAL VENOUS ACCESS IN CRITICALLY ILL Target Audience: Physicians and nurses providing care to patients in MultiCare
More informationYou have a what, inside you?
Costal Emergency Medicine Conference You have a what, inside you? Less than mainstream medical devices encountered in the ED. Eric Ossmann, MD, FACEP Associate Professor Duke University Medical Center
More information